Table 1 Patients and Transplantation characteristics.
Characteristics | Values |
|---|---|
Included survivors, n | 85 |
No. of males (%) | 44 (52) |
Patient-related characteristics, median (range) | |
Age at follow-up (years) | 30.4 (19.6-53.0) |
Time from transplantation to examination (years) | 19.9 (5.9-36.9) |
Age at transplantation (years) | 10.9 (0.4-17.9) |
Donor age (years) | 11.5 (1.7-47.6) |
Diagnosis, n (%) | |
Acute leukaemia | 42 (49) |
Other malignant disease | 15 (18) |
Non-malignant disease | 28 (33) |
Donor type, n (%) | |
HLA-identical sibling | 45 (53) |
Matched unrelated donor | 23 (27) |
Others | 17 (20) |
Graft type, n (%) | |
Bone marrow | 78 (92) |
Peripheral blood | 2 (2) |
Umbilical cord blood | 5 (6) |
Conditioning, n (%) | |
TBI-based conditioning regimes (applied for malign diagnoses) | 45 (53) |
BU + CY | 24 (28) |
Other | 16 (19) |
GvHD, n (%) | |
Acute GvHD | |
Grade 0–I | 60 (70) |
Grade II–IV | 25 (30) |
Chronic GvHD | |
Yes | 21 (25) |
No | 64 (75) |
